In addition, lower serum levels of TNF-α and IL-6 were also detected in the SPRC group (Figure 1C), suggesting that SPRC treatment effectively ameliorated the symptoms and inflammatory responses of arthritis in AIA rats. This evidence concerns the gene SPRR3 and arthritic joint disease.